<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04233957</url>
  </required_header>
  <id_info>
    <org_study_id>1452626</org_study_id>
    <nct_id>NCT04233957</nct_id>
  </id_info>
  <brief_title>Dietary Sodium, Oxidative Stress, and Pulsatile Hemodynamics</brief_title>
  <official_title>The Role of Oxidative Stress and Endothelial Dysfunction in High Sodium-Induced Changes in Pulsatile Hemodynamics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Delaware</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Delaware</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      High sodium diets impair vascular function, which may influence the work of the heart. This
      investigation is designed to determine if this change in vascular function results in a
      greater workload in the heart and if people who regularly exercise are protected from these
      effects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Excess dietary sodium is associated with cardiac hypertrophy independent of changes in blood
      pressure. Importantly, increased arterial pulsatile load predicts left ventricular
      hypertrophy, and thus presents a potential mechanism through which high dietary sodium
      augments cardiovascular disease risk.

      While high sodium diets impair vascular function via an increase in oxidative stress, how
      high sodium influences central pulsatile hemodynamics is not known. This project aims to a)
      determine how impaired vascular function affects pulsatile hemodynamics and thus influences
      the work of the heart during periods of high sodium consumption and b) examine whether
      regular aerobic exercise and/or fitness protects against the deleterious effects of excess
      sodium.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reflected Pulse Wave Amplitude</measure>
    <time_frame>On the 10th day of each arm.</time_frame>
    <description>Aortic pressure-flow relations will be assessed non-invasively using echocardiography and peripheral artery applanation tonometry. Wave separation analysis will be used to calculate reflected pulse wave amplitude.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Conduit artery endothelium-dependent dilation</measure>
    <time_frame>On the 10th day of each arm.</time_frame>
    <description>Brachial artery flow mediated dilation (FMD) will be assessed by duplex ultrasound as an index of conduit artery endothelial function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arterial Stiffness</measure>
    <time_frame>On the 10th day of each arm.</time_frame>
    <description>Carotid-femoral pulse wave velocity (cf-PWV) will be assessed via applanation tonometry as an index of aortic stiffness. cf-PWV will be calculated as the difference in timing of of pulse waves at the carotid and femoral arteries divided by the distance between measurements.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wave reflection timing</measure>
    <time_frame>On the 10th day of each arm.</time_frame>
    <description>Aortic pressure-flow relations will be assessed non-invasively using echocardiography and peripheral artery applanation tonometry. Wave separation analysis will be used to calculate reflected wave transit time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forward Pulse Wave Amplitude</measure>
    <time_frame>On the 10th day of each arm.</time_frame>
    <description>Aortic pressure-flow relations will be assessed non-invasively using echocardiography and peripheral artery applanation tonometry. Wave separation analysis will be used to the amplitude of the forward traveling pulse wave.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24 Hour Blood Pressure</measure>
    <time_frame>The morning of day 9 through the morning of day 10 for each arm.</time_frame>
    <description>24 hour blood pressure monitoring will be performed using an ambulatory blood pressure monitor device. Average day and nighttime systolic, diastolic, and mean blood pressures will be determined.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Sodium Excess</condition>
  <arm_group>
    <arm_group_label>High Sodium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consumption of an extra 3900 mg of dietary sodium per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control Condition</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High Sodium</intervention_name>
    <description>10 days of 3900 mg of sodium/day in excess of normal dietary intake delivered via enteric capsules filled with table salt.</description>
    <arm_group_label>High Sodium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>10 days of enteric capsules filled with dextrose.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy individuals (age 21-45) who are either sedentary (1 or less days of exercise
             per week during past year) or habitually active (4 or more days of aerobic exercise
             per week for a minimum of 1 year)

        Exclusion Criteria:

          -  Body mass index &lt;18 or &gt;35

          -  Systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90

          -  Blood donation within past 8 weeks,

          -  Glucose 6 phosphate dehydrogenase (G6PD) deficiency

          -  A history of cancer, diabetes, or any other chronic disease

          -  A history of any heart disease

          -  A history of hormone therapy

          -  Use of nicotine products

          -  Pregnancy

          -  Nursing mothers

          -  Participation in regular physical activity greater than 1 day/week- but less than 4
             days/week
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David G Edwards, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Delaware</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David G Edwards, PhD</last_name>
    <phone>302-831-3363</phone>
    <email>dge@udel.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jordan C Patik, PhD</last_name>
    <phone>512-820-6387</phone>
    <email>jpatik@udel.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Kinesiology and Applied Physiology, University of Delaware</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Edwards, PhD</last_name>
      <email>dge@udel.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jordan Patik, PhD</last_name>
      <email>jpatik@udel.edu</email>
    </contact_backup>
    <investigator>
      <last_name>David Edwards, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jordan Patik, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 23, 2019</study_first_submitted>
  <study_first_submitted_qc>January 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>January 16, 2020</last_update_submitted>
  <last_update_submitted_qc>January 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endothelium</keyword>
  <keyword>oxidative stress</keyword>
  <keyword>physical activity</keyword>
  <keyword>ventricular-vascular coupling</keyword>
  <keyword>pulsatile load</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypernatremia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

